23 November 2023
Doctors’ training on vitiligo in the D.R.C
The Association Franco-Congolaise du Vitiligo (AFCV), which was created in…
20 October 2023
Upadacitinib Meets Primary End Point of Phase 2 Trial for Vitiligo and Advances to Phase 3
AbbVie recently announced that its phase 2b study investigating upadacitinib (Rinvoq)…
18 May 2023
New therapy for vitiligo patients
For a long time, vitiligo was considered purely a cosmetic…
1 November 2022
VIPOC Appoints Mrs. Gaone Matewa As New President
…
